Task: Answer the multiple choice question.
Question: Which drug exhibits a 16.933% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) Cc1ccc(-n2nnc3c(=O)n(CC(=O)NCc4ccco4)cnc32)cc1
(b) CCS(=O)(=O)N1Cc2ccccc2CC1C(=O)N(C)Cc1ccc(OC)cc1OC
Answer: b. CCS(=O)(=O)N1Cc2ccccc2CC1C(=O)N(C)Cc1ccc(OC)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCS(=O)(=O)N1Cc2ccccc2CC1C(=O)N(C)Cc1ccc(OC)cc1OC
CCS(=O)(=O)N1Cc2ccccc2CC1C(=O)N(C)Cc1ccc(OC)cc1OC
N-[(2,4-dimethoxyphenyl)methyl]-2-ethylsulfonyl-N-methyl-3,4-dihydro-1H-isoquinoline-3-carboxamide